Cipla, Amgen Settle Case Involving Generic Cinacalcet Hydrochloride Tablets
New Delhi: Drug giant Cipla on Monday said it has reached a settlement with Amgen Inc on pending litigation involving generic cinacalcet hydrochloride tablets, used in treatment of secondary hyperparathyroidism…
Share